Dergiler / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 4

Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience

Sayfa
703–708
Yayın Tarihi
2014-05-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Thus, anesthesiologists will be confronted with a number of TAVI cases, and so they should be prepared to face issues related to the patient's safety both during the administration of anesthesia and in the postoperative period in the near future.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To describe the anesthetic management and early results of transcatheter aortic valve implantation (TAVI) in a single center in Turkey.
📊
Temel Bulgular & Veri:Materials and methods: We evaluated 79 (54 females, 25 males; mean age: 76 ± 9 years) consecutive symptomatic patients with severe aortic stenosis who underwent TAVI under general anesthesia between July 2011 and September 2012.
💡
Sonuç & Katkı:Thus, anesthesiologists will be confronted with a number of TAVI cases, and so they should be prepared to face issues related to the patient's safety both during the administration of anesthesia and in the postoperative period in the near future.
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Key words: Transcatheter aortic valve implantation · anesthetic management · aortic stenosis

Özet

To describe the anesthetic management and early results of transcatheter aortic valve implantation (TAVI) in a single center in Turkey. Materials and methods: We evaluated 79 (54 females, 25 males; mean age: 76 ± 9 years) consecutive symptomatic patients with severe aortic stenosis who underwent TAVI under general anesthesia between July 2011 and September 2012. We preferred a transfemoral approach as the first option. Results: The duration of anesthesia was 149 ± 49 min. Thirty-eight percent of the patients were extubated in the cardiac catheterization laboratory. Three patients required a permanent pacemaker, while 8 patients required inotropic support in the postoperative period. Mortality rate was 9% within 30 days. Fifteen patients had vascular complications, of which 53% were treated surgically. Conclusion: Today, as a result of developments in technology, TAVI can be considered as a beneficial alternative treatment option for inoperable aortic stenosis patients. Thus, anesthesiologists will be confronted with a number of TAVI cases, and so they should be prepared to face issues related to the patient's safety both during the administration of anesthesia and in the postoperative period in the near future.

Abstract

To describe the anesthetic management and early results of transcatheter aortic valve implantation (TAVI) in a single center in Turkey. Materials and methods: We evaluated 79 (54 females, 25 males; mean age: 76 ± 9 years) consecutive symptomatic patients with severe aortic stenosis who underwent TAVI under general anesthesia between July 2011 and September 2012. We preferred a transfemoral approach as the first option. Results: The duration of anesthesia was 149 ± 49 min. Thirty-eight percent of the patients were extubated in the cardiac catheterization laboratory. Three patients required a permanent pacemaker, while 8 patients required inotropic support in the postoperative period. Mortality rate was 9% within 30 days. Fifteen patients had vascular complications, of which 53% were treated surgically. Conclusion: Today, as a result of developments in technology, TAVI can be considered as a beneficial alternative treatment option for inoperable aortic stenosis patients. Thus, anesthesiologists will be confronted with a number of TAVI cases, and so they should be prepared to face issues related to the patient's safety both during the administration of anesthesia and in the postoperative period in the near future.

🔖

Bu Makaleye Atıf Yap

GÜMÜŞ, T., KESİMCİ, E., SOYKUT, C., KANBAK, O., BUT, A. (2014). Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 4, 703–708. https://ajindex.com/articles/228080

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Bärwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 24: 2714–2720.
  2. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755–763.
  3. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007; 116: 1240–1245.
  4. Patel PA, Ramakrishna H, Andritsos M, Wyckoff T, Riha H, Augoustides JG. The year in cardiothoracic and vascular anesthesia: selected highlights from 2011. J Cardiothorac Vasc Anesth 2012; 26: 3–10.
  5. Bauernschmitt R, Schreiber C, Bleiziffer S, Ruge H, Mazzitelli D, Hutter A, Tassani P, Lange R. Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients. Heart Surg Forum 2009; 12: E63–64. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. Engl J Med 2010; 363: 1597–1607.
  6. Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchère S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A et al. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010; 24: 752–761.
  7. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29: 1463–1470.
  8. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self- expanding CoreValve